Differential regulation of the plasminogen activator inhibitor-1 (PAI-1) gene expression by growth factors and progesterone in human endometrial stromal cells
- PMID: 9358004
- DOI: 10.1093/molehr/3.9.781
Differential regulation of the plasminogen activator inhibitor-1 (PAI-1) gene expression by growth factors and progesterone in human endometrial stromal cells
Abstract
Plasminogen activator inhibitor-1 (PAI-1) has important regulatory functions in haemostasis, extracellular matrix turn-over and cell adhesion. We studied PAI-1 gene expression in primary cultures of endometrial stromal cells, and found that PAI-1 protein and mRNA were increased both by agents associated with differentiation, i.e. progesterone and transforming growth factor beta1 (TGFbeta1), and by those promoting proliferation, i.e. epidermal growth factor (EGF), TGFalpha and basic fibroblast growth factor (bFGF). In order to further elucidate the mechanism of regulation, we transfected stromal cells with an expression construct containing 804 bp of the PAI-1 promoter fused to a chloramphenicol acetyl transferase (CAT) reporter gene. After stimulation with the polypeptide growth factors TGFbeta1, EGF and bFGF we found increased CAT activity, indicating that these stimulators had initiated interaction with the transfected promoter fragment. On the other hand, stimulation with progesterone did not increase CAT activity, even though these cells were perfectly able to respond with increased secretion of PAI-1 protein. Run off experiments demonstrated that progesterone increased the stability of PAI-1 mRNA in endometrial stromal cells. We conclude that the polypeptide growth factors TGFbeta1, EGF and bFGF increase PAI-1 expression by increasing gene transcription. Progesterone, on the other hand, does not interact with the 804 bp promoter region, but increases the stability of PAI-1 mRNA.
Similar articles
-
Transforming growth factor beta1 in the human endometrium. Cyclic variation, increased expression by estradiol and progesterone, and regulation of plasminogen activators and plasminogen activator inhibitor-1.Biol Reprod. 1998 Jun;58(6):1343-50. doi: 10.1095/biolreprod58.6.1343. Biol Reprod. 1998. PMID: 9623591
-
Impact of epidermal growth factor and transforming growth factor beta-1 on the release of fibrinolytic factors from cultured endometrial and ovarian endometriotic stromal cells.Gynecol Obstet Invest. 2003;55(1):7-13. doi: 10.1159/000068950. Gynecol Obstet Invest. 2003. PMID: 12624545
-
Regulation of plasminogen activator inhibitor-1 mRNA accumulation by basic fibroblast growth factor and transforming growth factor-beta1 in cultured rat astrocytes.J Neurochem. 1998 Nov;71(5):1944-52. doi: 10.1046/j.1471-4159.1998.71051944.x. J Neurochem. 1998. PMID: 9798919
-
Biological mechanisms underlying the clinical effects of mifepristone (RU 486) on the endometrium.Early Pregnancy (Cherry Hill). 2000 Oct;4(4):230-9. Early Pregnancy (Cherry Hill). 2000. PMID: 11742418 Review.
-
Regulation of endometrial differentiation by synthetic steroids in vitro.Ann N Y Acad Sci. 1994 Sep 30;734:237-44. doi: 10.1111/j.1749-6632.1994.tb21753.x. Ann N Y Acad Sci. 1994. PMID: 7978923 Review. No abstract available.
Cited by
-
New insights on the potential effect of progesterone in Covid-19: Anti-inflammatory and immunosuppressive effects.Immun Inflamm Dis. 2023 Nov;11(11):e1100. doi: 10.1002/iid3.1100. Immun Inflamm Dis. 2023. PMID: 38018575 Free PMC article. Review.
-
Transforming growth factor-beta1 attenuates expression of both the progesterone receptor and Dickkopf in differentiated human endometrial stromal cells.Mol Endocrinol. 2008 Mar;22(3):716-28. doi: 10.1210/me.2007-0316. Epub 2007 Nov 21. Mol Endocrinol. 2008. PMID: 18032694 Free PMC article.
-
Mechanisms of abruption-induced premature rupture of the fetal membranes: thrombin-enhanced interleukin-8 expression in term decidua.Am J Pathol. 2005 Nov;167(5):1443-9. doi: 10.1016/S0002-9440(10)61230-8. Am J Pathol. 2005. PMID: 16251427 Free PMC article.
-
Uterine bleeding: how understanding endometrial physiology underpins menstrual health.Nat Rev Endocrinol. 2022 May;18(5):290-308. doi: 10.1038/s41574-021-00629-4. Epub 2022 Feb 8. Nat Rev Endocrinol. 2022. PMID: 35136207 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous